A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
figureposted on 2020-08-14, 13:48 authored by David E. Lanfear, Kelsey R. Neaton, Chen Lu, Yimeng Liu, Ricardo E. Dent-Acosta
Article full text
The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.